Srivichaivejvivat PCL's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Srivichaivejvivat PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Srivichaivejvivat PCL's highest Yield on Cost was 11.49. The lowest was 1.39. And the median was 3.85.
BKK:VIH-R's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.82 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Srivichaivejvivat PCL 5-Year Yield-on-Cost % Related Terms
BKK:VIH-R vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Srivichaivejvivat PCL (BKK:VIH-R) has a 5-Year Yield-on-Cost % of 0.00 as of Jun. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Srivichaivejvivat PCL and its competitors. Over the past decade, Srivichaivejvivat PCL's 5-Year Yield-on-Cost % has ranged from 1.39 to 11.49. According to the industry distribution chart, Srivichaivejvivat PCL ranks #30 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 10.7%.
Is Srivichaivejvivat PCL's 5-Year Yield-on-Cost % too high?
Srivichaivejvivat PCL's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 11.49. Based on the distribution chart, Srivichaivejvivat PCL ranks #30 out of 281 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Srivichaivejvivat PCL has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #30 out of 281 companies for 5-Year Yield-on-Cost %. This places Srivichaivejvivat PCL in the top 11% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.82. Historically, Srivichaivejvivat PCL's own 5-Year Yield-on-Cost % has ranged from 1.39 to 11.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.82, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Srivichaivejvivat PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is ฿8.96, compared to a current price of ฿8.95 — trading 0.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Srivichaivejvivat PCL's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current 5-Year Yield-on-Cost % is 0.00 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be undervalued.
The current stock price of ฿8.95 is trading 0.1% below its estimated GF Value™ of ฿8.96.
Key valuation signals for BKK:VIH-R:
5-Year Yield-on-Cost %: 0.00
GF Value™: ฿8.96 vs. price of ฿8.95 (0.1% below fair value)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
80GF Score
Get the complete analysis for BKK:VIH-R
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 